PMID- 10589939 OWN - NLM STAT- MEDLINE DCOM- 19991221 LR - 20190713 IS - 0041-1337 (Print) IS - 0041-1337 (Linking) VI - 68 IP - 10 DP - 1999 Nov 27 TI - Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver. PG - 1459-68 AB - BACKGROUND: The monocyte chemoattractant protein-1 (MCP-1) is produced during reperfusion injury and induces tissue factor that is the initiator of the clotting cascade. Neutrophil elastase is a crucial mediator of inflammatory tissue damage. Activation of the coagulation system stimulates cytokine production by activated leukocytes. We investigated the effects of neutrophil elastase and oxygen radicals generated by hypoxia associated with microthrombus formation on MCP-1 expression after ischemia/reperfusion in rat liver. METHODS: In vitro MCP-1 production by macrophages after stimulation with human neutrophil elastase (HNE) or oxygen radicals generated by hypoxanthine and xanthine oxidase was examined. Liver ischemia was induced in rats by occluding the portal vein for 30 min. An inhibitor of human neutrophil elastase (ONO-5046*Na, 10 mg/kg) and antithrombin III (AT-III, 250 U/kg) were injected i.v. 5 min before vascular clamping. Serum concentrations of MCP-1 were measured by enzyme-linked immunosorbent assay. RESULTS: Human neutrophil elastase or oxygen radicals significantly enhanced in vitro MCP-1 production by macrophage. Serum MCP-1 concentrations reached a peak at 6 hr after reperfusion and then gradually decreased. However, pretreatment of animals with AT-III or ONO-5046*Na alone resulted in significantly smaller increases in serum concentrations of MCP-1 after reperfusion. Pretreatment with both ONO-5046*Na and AT-III produced additive effects. The combined treatment with ONO-5046*Na and AT-III significantly reduced MCP-1 mRNA in liver after ischemia/reperfusion. CONCLUSIONS: MCP-1 production by macrophages is stimulated by neutrophil elastase and oxygen radicals generated by hypoxia, probably due to microthrombus formation after ischemia/reperfusion of the rat liver. FAU - Yamaguchi, Y AU - Yamaguchi Y AD - Department of Surgery II, Kumamoto University Medical School, Japan. FAU - Matsumura, F AU - Matsumura F FAU - Liang, J AU - Liang J FAU - Okabe, K AU - Okabe K FAU - Ohshiro, H AU - Ohshiro H FAU - Ishihara, K AU - Ishihara K FAU - Matsuda, T AU - Matsuda T FAU - Mori, K AU - Mori K FAU - Ogawa, M AU - Ogawa M LA - eng PT - Journal Article PL - United States TA - Transplantation JT - Transplantation JID - 0132144 RN - 0 (Chemokine CCL2) RN - 0 (Serine Proteinase Inhibitors) RN - 0 (Sulfonamides) RN - 11062-77-4 (Superoxides) RN - 9000-94-6 (Antithrombin III) RN - BBX060AN9V (Hydrogen Peroxide) RN - DWI62G0P59 (sivelestat) RN - EC 3.4.21.37 (Leukocyte Elastase) RN - TE7660XO1C (Glycine) SB - IM MH - Animals MH - Antithrombin III/pharmacology MH - Cell Hypoxia MH - Cells, Cultured MH - Chemokine CCL2/blood/*genetics MH - Enzyme-Linked Immunosorbent Assay MH - Gene Expression Regulation MH - Glycine/analogs & derivatives/pharmacology MH - Humans MH - Hydrogen Peroxide/pharmacology MH - Ischemia/*metabolism MH - Kupffer Cells/drug effects/metabolism MH - Leukocyte Elastase/antagonists & inhibitors/*metabolism/pharmacology MH - Liver/*blood supply/*metabolism MH - Macrophages, Peritoneal/drug effects/metabolism MH - Male MH - Rats MH - Rats, Wistar MH - *Reperfusion MH - Serine Proteinase Inhibitors/pharmacology MH - Sulfonamides/pharmacology MH - Superoxides/*pharmacology MH - Transcription, Genetic EDAT- 1999/12/10 00:00 MHDA- 1999/12/10 00:01 CRDT- 1999/12/10 00:00 PHST- 1999/12/10 00:00 [pubmed] PHST- 1999/12/10 00:01 [medline] PHST- 1999/12/10 00:00 [entrez] AID - 10.1097/00007890-199911270-00005 [doi] PST - ppublish SO - Transplantation. 1999 Nov 27;68(10):1459-68. doi: 10.1097/00007890-199911270-00005.